These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28711678)

  • 21. Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-positive bacterial infections.
    Lopez-Garcia B; Luque S; Roberts JA; Grau S
    J Infect; 2015 Nov; 71(5):604-7. PubMed ID: 26099449
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia.
    Xie F; Mantzarlis K; Malliotakis P; Koulouras V; Degroote S; Koulenti D; Blot S; Boussery K; Van Bocxlaer J; Colin P;
    J Antimicrob Chemother; 2019 Mar; 74(3):667-674. PubMed ID: 30535122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
    Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
    J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
    Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors associated with high linezolid trough plasma concentrations.
    Morata L; De la Calle C; Gómez-Cerquera JM; Manzanedo L; Casals G; Brunet M; Cobos-Trigueros N; Martínez JA; Mensa J; Soriano A
    Expert Opin Pharmacother; 2016 Jun; 17(9):1183-7. PubMed ID: 27156708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients.
    Dong H; Xie J; Wang T; Chen L; Zeng X; Sun J; Wang X; Dong Y
    Int J Antimicrob Agents; 2016 Sep; 48(3):259-64. PubMed ID: 27474469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosage regimen and toxicity risk assessment of linezolid in sepsis patients.
    Dou L; Meng D; Dong Y; Chen L; Han X; Fan D; Dong H
    Int J Infect Dis; 2020 Jul; 96():105-111. PubMed ID: 32251797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics and target attainment analysis of linezolid in multidrug-resistant tuberculosis patients.
    Tietjen AK; Kroemer N; Cattaneo D; Baldelli S; Wicha SG
    Br J Clin Pharmacol; 2022 Feb; 88(4):1835-1844. PubMed ID: 34622478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.
    Crass RL; Cojutti PG; Pai MP; Pea F
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and Pharmacodynamics of Linezolid in Patients With Sepsis Receiving Continuous Venovenous Hemofiltration and Extended Daily Hemofiltration.
    Zheng J; Sun Z; Sun L; Zhang X; Hou G; Han Q; Li X; Liu G; Gao Y; Ye M; Wang H; Yu K
    J Infect Dis; 2020 Mar; 221(Suppl 2):S279-S287. PubMed ID: 32176792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.
    Tsuji Y; Holford NHG; Kasai H; Ogami C; Heo YA; Higashi Y; Mizoguchi A; To H; Yamamoto Y
    Br J Clin Pharmacol; 2017 Aug; 83(8):1758-1772. PubMed ID: 28186644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration.
    Corcione S; D'Avolio A; Allegra S; Fanelli V; Urbino R; Ranieri MV; Di Perri G; De Rosa FG
    Int J Antimicrob Agents; 2017 Jun; 49(6):784-785. PubMed ID: 28412274
    [No Abstract]   [Full Text] [Related]  

  • 34. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
    Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
    Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
    J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid underexposure in a patient co-treated with venlafaxine.
    Cojutti P; Crapis M; Bassetti M; Hope W; Pea F
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1285-6. PubMed ID: 26253645
    [No Abstract]   [Full Text] [Related]  

  • 37. Augmented renal clearance in the Intensive Care Unit: an illustrative case series.
    Udy AA; Putt MT; Shanmugathasan S; Roberts JA; Lipman J
    Int J Antimicrob Agents; 2010 Jun; 35(6):606-8. PubMed ID: 20307958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
    Stalker DJ; Jungbluth GL
    Clin Pharmacokinet; 2003; 42(13):1129-40. PubMed ID: 14531724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of hepatic function in new cases of pulmonary tuberculosis due to the use of standard chemotherapy regimens I and IIB].
    Abdullaev RIu; Vaniev EV; Kaminskaia GO; Vasil'eva IA; Komissarova OG
    Probl Tuberk Bolezn Legk; 2009; (2):57-61. PubMed ID: 19382645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial changes in liver function tests in patients with subacute thyroiditis.
    Matsumoto Y; Amino N; Kubota S; Ikeda N; Morita S; Nishihara E; Ohye H; Kudo T; Ito M; Fukata S; Miyauchi A
    Thyroid; 2008 Jul; 18(7):815-6. PubMed ID: 18631018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.